MIC
PFE icon

Means Investment Company’s Pfizer PFE Stock Holding History

Means Investment Company’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$367K Buy
13,058
+124
+1% +$3.3K 0.03% 147
2025
Q4 		$322K Buy
12,934
+4,346
+51% +$110K 0.03% 151
2025
Q3 		$219K Sell
8,588
-6,099
-42% -$151K 0.02% 182
2025
Q2 		$356K Sell
14,687
-22,379
-60% -$522K 0.03% 149
2025
Q1 		$939K Sell
37,066
-27,907
-43% -$730K 0.1% 88
2024
Q4 		$1.72M Buy
64,973
+1,661
+3% +$45.1K 0.18% 68
2024
Q3 		$1.83M Buy
63,312
+21,939
+53% +$640K 0.2% 65
2024
Q2 		$1.16M Buy
41,373
+11,423
+38% +$314K 0.14% 84
2024
Q1 		$831K Sell
29,950
-4,332
-13% -$120K 0.11% 97
2023
Q4 		$987K Sell
34,282
-4,785
-12% -$145K 0.14% 93
2023
Q3 		$1.3M Sell
39,067
-609
-2% -$21.5K 0.21% 78
2023
Q2 		$1.46M Sell
39,676
-3,420
-8% -$133K 0.23% 78
2023
Q1 		$1.76M Sell
43,096
-957
-2% -$41.3K 0.31% 63
2022
Q4 		$2.26M Buy
44,053
+1,307
+3% +$62.7K 0.45% 49
2022
Q3 		$1.87M Sell
42,746
-809
-2% -$39.3K 0.41% 54
2022
Q2 		$2.28M Buy
43,555
+392
+0.9% +$20K 0.48% 46
2022
Q1 		$2.23M Buy
43,163
+995
+2% +$51.6K 0.4% 52
2021
Q4 		$2.49M Sell
42,168
-43
-0.1% -$2.13K 0.44% 49
2021
Q3 		$1.81M Sell
42,211
-228
-0.5% -$10.1K 0.36% 56
2021
Q2 		$1.66M Buy
42,439
+2,637
+7% +$103K 0.33% 62
2021
Q1 		$1.44M Buy
39,802
+691
+2% +$24.5K 0.33% 62
2020
Q4 		$1.35M Buy
39,111
+1,969
+5% +$72.2K 0.31% 63
2020
Q3 		$1.28M Sell
37,142
-5,230
-12% -$183K 0.35% 55
2020
Q2 		$1.52M Sell
42,372
-319
-0.7% -$10.8K 0.48% 46
2020
Q1 		$1.47M Sell
42,691
-788
-2% -$26.9K 0.57% 47
2019
Q4 		$1.67M Sell
43,479
-456
-1% -$16.2K 0.56% 51
2019
Q3 		$1.58M Sell
43,935
-1,971
-4% -$71.7K 0.6% 51
2019
Q2 		$1.89M Sell
45,906
-2,890
-6% -$115K 0.77% 43
2019
Q1 		$1.97M Buy
48,796
+3,879
+9% +$155K 0.86% 36
2018
Q4 		$1.86M Buy
+44,917
New +$1.86M 1.03% 28

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Means Investment Company's PFE Position: Q1 2026 in Review

Means Investment Company increased its Pfizer (PFE) stake by 0.96% in Q1 2026, buying an estimated $3.3K and bringing the position to 13,058 shares worth $367K. The position accounts for 0.03% of the portfolio, ranked #147.

Means Investment Company first reported a position in PFE in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.49M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Means Investment Company held 13,058 shares of Pfizer worth $367K as of Q1 2026.
  • Means Investment Company bought 124 Pfizer shares in Q1 2026, an estimated $3.3K.
  • Pfizer made up 0.03% of Means Investment Company's portfolio in Q1 2026, its #147 holding.
  • Means Investment Company first reported a position in Pfizer in Q4 2018 and has held it in 30 quarters since.
  • Means Investment Company's Pfizer position peaked at $2.49M in Q4 2021.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Means Investment Company's 13F filing for Q1 2026, filed 24 Apr 2026.